Chemokine MIP-2/CXCL2, Acting on CXCR2, Induces Motor Neuron Death in Primary Cultures

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Neuroimmunomodulation

• Publication date

  2008-04-03

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1159/000123834PMID 18391506
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• IL-8 Induces Expression of Matrix Metalloproteinases, Cell Cycle and Pro-Apoptotic Proteins, and Cell Death in Cultured Neurons

  2007cited by this paper
• Multiple Sclerosis

  2007cited by this paper
• The Interleukin-8 (IL-8/CXCL8) Receptor Inhibitor Reparixin Improves Neurological Deficits and Reduces Long-term Inflammation in Permanent and Transient Cerebral Ischemia in Rats

  2007cited by this paper
• Reparixin, an Inhibitor of CXCR2 Function, Attenuates Inflammatory Responses and Promotes Recovery of Function after Traumatic Lesion to the Spinal Cord

  2007cited by this paper
• Role for CXCR2 and CXCL1 on glia in multiple sclerosis

  2006cited by this paper
• Survival of Patients with Amyotrophic Lateral Sclerosis in a Population-Based Registry

  2005cited by this paper
• Microglia as potential contributors to motor neuron injury in amyotrophic lateral sclerosis

  2005cited by this paper
• CXC chemokine receptors on human oligodendrocytes: implications for multiple sclerosis.

  2005cited by this paper
• Production of monocyte chemoattractant protein‐1 in amyotrophic lateral sclerosis

  2005cited by this paper
• Neuroprotection with the CXCL8 inhibitor repertaxin in transient brain ischemia.

  2005cited by this paper
• Elevated IL-6 and TNF-alpha levels in patients with ALS: inflammation or hypoxia?

  2005cited by this paper
• Elevated IL-6 and TNF-α levels in patients with ALS: Inflammation or hypoxia?

  2005cited by this paper
• Chemokine receptors in the central nervous system: role in brain inflammation and neurodegenerative diseases.

  2005cited by this paper
• Interleukin‐12 and interferon‐γ are not detectable in the cerebrospinal fluid of patients with amyotrophic lateral sclerosis

  2004cited by this paper
• Monocyte chemoattractant protein-1 and macrophage inflammatory protein-2 are involved in both excitotoxin-induced neurodegeneration and regeneration.

  2004cited by this paper
• Excitotoxic and oxidative cross-talk between motor neurons and glia in ALS pathogenesis.

  2004cited by this paper
• Noncompetitive allosteric inhibitors of the inflammatory chemokine receptors CXCR1 and CXCR2: prevention of reperfusion injury.

  2004cited by this paper
• A role for astrocytes in motor neuron loss in amyotrophic lateral sclerosis.

  2004cited by this paper
• Signaling pathways activated by chemokine receptor CXCR2 and AMPA-type glutamate receptors and involvement in granule cells survival.

  2002cited by this paper
• GROalpha/KC, a chemokine receptor CXCR2 ligand, can be a potent trigger for neuronal ERK1/2 and PI-3 kinase pathways and for tau hyperphosphorylation-a role in Alzheimer's disease?

  2002cited by this paper
• GROα/KC, a chemokine receptor CXCR2 ligand, can be a potent trigger for neuronal ERK1/2 and PI-3 kinase pathways and for tau hyperphosphorylation—a role in Alzheimer's disease?

  2002cited by this paper
• Cerebrospinal fluid from patients with neurodegenerative and neuroinflammatory diseases: no evidence for rat glial activation in vitro.

  2001cited by this paper
• Nitric oxide produced by non-motoneuron cells enhances rat embryonic motoneuron sensitivity to excitotoxins: comparison in mixed neuron/glia or purified cultures.

  2001cited by this paper
• Circulating levels of tumour necrosis factor-alpha and its soluble receptors are increased in the blood of patients with amyotrophic lateral sclerosis.

  2000cited by this paper
• Clinical features of amyotrophic lateral sclerosis according to the El Escorial and Airlie House diagnostic criteria: A population-based study.

  2000cited by this paper
• The chemokine growth-related gene product beta protects rat cerebellar granule cells from apoptotic cell death through alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptors.

  2000cited by this paper
• Neuroprotective activity of chemokines against N-methyl-D-aspartate or beta-amyloid-induced toxicity in culture.

  2000cited by this paper
• The chemokine growth-related gene product β protects rat cerebellar granule cells from apoptotic cell death through α-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptors

  2000cited by this paper
• Age effects on interleukin-6 and interleukin-1beta responses to endurance exercise in patients with neuromuscular diseases.

  1999cited by this paper
• Cerebrospinal fluid interleukin 6 in amyotrophic lateral sclerosis: immunological parameter and comparison with inflammatory and non-inflammatory central nervous system diseases.

  1998cited by this paper
• Expression of chemokine receptors by subsets of neurons in the central nervous system.

  1997cited by this paper
• Survival prediction in sporadic amyotrophic lateral sclerosis. Age and clinical form at onset are independent risk factors.

  1996cited by this paper
• Prognosis of amyotrophic lateral sclerosis and the effect of referral selection.

  1995cited by this paper
• Intrathecal synthesis of interleukin-10 (IL-10) in viral and inflammatory diseases of the central nervous system.

  1994cited by this paper
• Trophic effects of interleukin-4, -7 and -8 on hippocampal neuronal cultures: potential involvement of glial-derived factors.

  1993cited by this paper
• Amyotrophic Lateral Sclerosis: Interleukin-6 Levels in Cerebrospinal Fluid

  1992cited by this paper

• The multifaceted role of the CXC chemokines and receptors signaling axes in ALS pathophysiology.

  2024cites this paper
• Dexmedetomidine Attenuated Neuron Death, Cognitive Decline, and Anxiety-Like Behavior by Inhibiting CXCL2 in CA1 Region of AD Mice

  2024cites this paper
• Rodent Model of Cardiopulmonary Bypass Demonstrates Systemic Inflammation and NeuroMarker Changes.

  2024cites this paper
• Quercetin protects against sepsis-associated encephalopathy by inhibiting microglia-neuron crosstalk via the CXCL2/CXCR2 signaling pathway.

  2024cites this paper
• Emerging diagnostic markers and therapeutic targets in post-stroke hemorrhagic transformation and brain edema

  2023cites this paper
• Blocking CXC Motif Chemokine Ligand 2 Ameliorates Diabetic Peripheral Neuropathy via Inhibiting Apoptosis and NLRP3 Inflammasome Activation.

  2023cites this paper
• CXCR2 Is Deregulated in ALS Spinal Cord and Its Activation Triggers Apoptosis in Motor Neuron-Like Cells Overexpressing hSOD1-G93A

  2023cites this paper
• Potential neurotoxic activity of diverse molecules released by astrocytes.

  2022cites this paper
• Beneficial Effects of Spirulina Consumption on Brain Health

  2022cites this paper
• CXCR2 increases in ALS cortical neurons and its inhibition prevents motor neuron degeneration in vitro and improves neuromuscular function in SOD1G93A mice.

  2021cites this paper
• Evaluating the endothelial-microglial interaction and comprehensive inflammatory marker profiles under acute exposure to ultrafine diesel exhaust particles in vitro.

  2021cites this paper
• Modulating neuroinflammation in neurodegeneration-related dementia: can microglial toll-like receptors pull the plug?

  2021cites this paper
• Chemokines gene expression in the prefrontal cortex of depressed suicide victims and normal control subjects.

  2021cites this paper
• Nutraceutical and therapeutic potential of Phycocyanobilin for treating Alzheimer’s disease

  2021cites this paper
• Brain injury and repair after Intracerebral hemorrhage: The role of microglia and brain-infiltrating macrophages.

  2020cites this paper
• Identification of inflammation-associated circulating long non-coding RNAs and genes in intracranial aneurysm rupture-induced subarachnoid hemorrhage

  2020cites this paper
• Neuregulin-1/ErbB Network: An Emerging Modulator of Nervous System Injury and Repair.

  2019cites this paper
• Expressions of chemokines and their receptors in the brain after heat stroke-induced cortical damage.

  2018cites this paper
• Postpartum increases in cerebral edema and inflammation in response to placental ischemia during pregnancy.

  2018cites this paper
• Microglia and CNS Interleukin-1: Beyond Immunological Concepts

  2018cites this paper
• MDSCs drive the process of endometriosis by enhancing angiogenesis and are a new potential therapeutic target

  2018cites this paper
• Neuregulin-1 elicits a regulatory immune response following traumatic spinal cord injury

  2018cites this paper
• Long-term incubation with CXCL2, but not with CXCL1, alters the kinetics of TRPV1 receptors in cultured dorsal root ganglia neurons

  2017cites this paper
• Selection and Prioritization of Candidate Drug Targets for Amyotrophic Lateral Sclerosis Through a Meta-Analysis Approach

  2017cites this paper
• Long-term exposure to CXCL 2 has cytotoxic effects on HEK 293 T cells stably expressing TRPV 1

  2017cites this paper
• A Potential Contribution of Chemokine Network Dysfunction to the Depressive Disorders

  2016cites this paper
• Transcriptional analysis reveals distinct subtypes in amyotrophic lateral sclerosis: implications for personalized therapy.

  2015cites this paper
• The sciatic nerve injury model in pre-clinical research.

  2015cites this paper
• Matrix-derived inflammatory mediator N-acetyl proline-glycine-proline is neurotoxic and upregulated in brain after ischemic stroke

  2015cites this paper
• CXCR1/2 Inhibition Blocks and Reverses Type 1 Diabetes in Mice

  2014cites this paper
• Can infections cause Alzheimer's disease?

  2013cites this paper
• A Systematic Analysis of the Peripheral and CNS Effects of Systemic LPS, IL-1Β, TNF-α and IL-6 Challenges in C57BL/6 Mice

  2013cites this paper
• Cytokines and Chemokines at the Crossroads of Neuroinflammation, Neurodegeneration, and Neuropathic Pain

  2013cites this paper
• Effects of heat shock protein 72 (Hsp72) on evolution of astrocyte activation following stroke in the mouse.

  2012cites this paper
• JCV agnoprotein‐induced reduction in CXCL5/LIX secretion by oligodendrocytes is associated with activation of apoptotic signaling in neurons

  2012cites this paper
• Chemokiny i ich receptory na neuronach a proces neurodegeneracji i neuroprotekcji

  2011cites this paper
• Low Molecular Weight CXCR2 Antagonists as Promising Therapeutics

  2011cites this paper
• Chemokines, macrophage inflammatory protein-2 and stromal cell-derived factor-1α, suppress amyloid β-induced neurotoxicity.

  2011cites this paper
• Role of Chemokines in CNS Health and Pathology: A Focus on the CCL2/CCR2 and CXCL8/CXCR2 Networks

  2010cites this paper
• P2X7 receptor activation induces CXCL2 production in microglia through NFAT and PKC/MAPK pathways

  2010cites this paper
• CXCR2 antagonists for the treatment of pulmonary disease.

  2009cites this paper
• Oral Neuroimmune Network and Mast Cells

  2009cites this paper
• Bacterial endotoxin activates retinal pigment epithelial cells and induces their degeneration through IL-6 and IL-8 autocrine signaling.

  2009cites this paper
• Chapter 4: Methods and protocols in peripheral nerve regeneration experimental research: part I-experimental models.

  2009cites this paper
• Increased Il-8 Levels in the Cerebrospinal Fluid of Patients with Amyotrophic Lateral Sclerosis

  2009cites this paper
• Nonerythropoietic, tissue-protective peptides derived from the tertiary structure of erythropoietin

  2008cites this paper